Related references
Note: Only part of the references are listed.Many Patients With Interleukin 28B Genotypes Associated With Response to Therapy Are Ineligible for Treatment Because of Comorbidities
Fasiha Kanwal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Hepatitis C Virus Testing of Persons Born During 1945-1965
Richard B. Lynn
ANNALS OF INTERNAL MEDICINE (2013)
Assessment of motivating factors associated with the initiation and completion of treatment for chronic hepatitis C virus (HCV) infection
Lauren Fusfeld et al.
BMC INFECTIOUS DISEASES (2013)
A Small Percentage of Patients With Hepatitis C Receive Triple Therapy With Boceprevir or Telaprevir
Emerson Y. Chen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
A global view of hepatitis C: Physician knowledge, opinions, and perceived barriers to care
Christopher E. McGowan et al.
HEPATOLOGY (2013)
Hepatitis C in the United States
Scott D. Holmberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Hepatitis C Virus Testing of Persons Born During 1945-1965: Recommendations From the Centers for Disease Control and Prevention
Bryce D. Smith et al.
ANNALS OF INTERNAL MEDICINE (2012)
The high comorbidity burden of the hepatitis C virus infected population in the United States
Karly S. Louie et al.
BMC INFECTIOUS DISEASES (2012)
A Watershed Moment in the Treatment of Hepatitis C
Raymond T. Chung
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C
Lisa I. Backus et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Formal Patient Education Improves Patient Knowledge of Hepatitis C in Vulnerable Populations
Miranda Surjadi et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Insurance Status and Treatment Candidacy of Hepatitis C Patients: Analysis of Population-Based Data from the United States
Maria Stepanova et al.
HEPATOLOGY (2011)
Impact of a sustained virological response on the long-term outcome of hepatitis C
Alfredo Alberti
LIVER INTERNATIONAL (2011)
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
Bruce R. Bacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C
J. O. Smith et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
The disposition of hepatitis C antibody-positive patients in an urban hospital
B. Putka et al.
JOURNAL OF VIRAL HEPATITIS (2009)
Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis
Bart J. Veldt et al.
ANNALS OF INTERNAL MEDICINE (2007)
Determinants of antiviral treatment initiation in a hepatitis C-infected population benefiting from universal health care coverage
Romain Moirand et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: A retrospective study
Savino Bruno et al.
HEPATOLOGY (2007)
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
Richard K. Sterling et al.
HEPATOLOGY (2006)
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
Gregory L. Armstrong et al.
ANNALS OF INTERNAL MEDICINE (2006)
High rates of uninsured among HCV-positive individuals
JP Ong et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
Empirically calibrated model of hepatitis C virus infection in the United States
JA Salomon et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Share Paper
